Global Health & Medicine

Focusing on global health and medicine.

Mitsuya H, Kokudo N

Global Health & Medicine. 2019; 1(1):1-2.

DOI: 10.35772/ghm.2019.01005

Population aging in Japan: policy transformation, sustainable development goals, universal health coverage, and social determinates of health.

Nakatani H

Global Health & Medicine. 2019; 1(1):3-10.

DOI: 10.35772/ghm.2019.01011

The role of the G20 economies in global health.

Akashi H, Ishizuka A, Lee S, Irie M, Oketani H, Akashi R

Global Health & Medicine. 2019; 1(1):11-15.

DOI: 10.35772/ghm.2019.01008

Challenges to eliminating the AIDS pandemic in China.

Tang Q, Lu H

Global Health & Medicine. 2019; 1(1):16-19.

DOI: 10.35772/ghm.2019.01013

Efficient and practical dissemination of information on viral hepatitis in Japan: an effort by the Hepatitis Information Center, National Center for Global Health and Medicine.

Kitayama Y, Korenaga M, Setoyama H, Kanto T

Global Health & Medicine. 2019; 1(1):20-22.

DOI: 10.35772/ghm.2019.01028

Hepatocellular carcinoma with non-B and non-C hepatitis origin: epidemiology in Japan and surgical outcome.

Kokudo N, Takemura N, Kanto T, Tateishi R, Igari T, Hasegawa K

Global Health & Medicine. 2019; 1(1):23-29.

DOI: 10.35772/ghm.019.01018

Diabetic dyslipidemia: evaluation and mechanism.

Yanai H, Hirowatari Y, Yoshida H

Global Health & Medicine. 2019; 1(1):30-35.

DOI: 10.35772/ghm.2019.01007

A novel HIV-1 protease inhibitor, GRL-044, has potent activity against various HIV-1s with an extremely high genetic barrier to the emergence of HIV-1 drug resistance.

Aoki M, Chang SB, Das D, Martyr C, Delino NS, Takamatsu Y, Ghosh AK, Mitsuya H

Global Health & Medicine. 2019; 1(1):36-48.

DOI: 10.35772/ghm.2019.01003

Non-AIDS-defining malignancies in Japanese hemophiliacs with HIV-1 infection.

Oka S, Ogata M, Takano M, Minamimoto R, Hotta M, Tajima T, Nagata N, Tsukada K, Teruya K, Kikuchi Y, Gatanaga H, the Cancer Screening in Hemophiliac/HIV Patient Study Group

Global Health & Medicine. 2019; 1(1):49-54.

DOI: 10.35772/ghm.2019.01015

Long-term outcomes in patients undergoing resection, ablation, and trans-arterial chemoembolization of hepatocellular carcinoma in the United States: a national cancer database analysis.

Kawaguchi Y, Chiang YJ, Velasco JD, Tzeng CD, Vauthey JN

Global Health & Medicine. 2019; 1(1):55-60.

DOI: 10.35772/ghm.2019.01029